Question 1

Are bio-identical hormones safer than synthetic HRT?

Accepted Answer

Bio-identical hormones are molecularly identical to your body's own hormones and have a different risk profile than synthetic alternatives. The French E3N study of 80,000+ women found that bio-identical oestradiol with micronised progesterone did not carry the breast cancer risk seen with synthetic progestins in the WHI study. "Safer" is context-dependent — all hormone therapy carries some risk and requires monitoring — but the evidence supports bio-identicals as a well-tolerated option.

Question 2

Is BHRT only for women going through menopause?

Accepted Answer

No. While menopause is the most common reason women seek BHRT, our protocol also serves perimenopausal women (symptoms can start years before menopause), men with multi-hormone decline, and younger individuals with premature ovarian insufficiency or other endocrine conditions. The "bio-identical" refers to the molecular structure of the hormones, not the patient population.

Question 3

How long will I need to stay on BHRT?

Accepted Answer

Duration depends on your individual situation and goals. For menopausal symptom relief, many women benefit from 5-10 years of therapy (current guidelines support this). Some patients choose longer-term use for bone density protection and cardiovascular health. Your physician will conduct annual risk-benefit reviews to ensure ongoing therapy remains appropriate.

BHRT (Bio-Identical Hormone Therapy)

Book a Consultation

Related Reading